Intrexon Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Intrexon's estimated annual revenue is currently $15.5M per year.(i)
  • Intrexon's estimated revenue per employee is $155,000

Employee Data

  • Intrexon has 100 Employees.(i)
  • Intrexon grew their employee count by -11% last year.

Intrexon's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15640M246141N/AN/A$109.8B
Add Company

What Is Intrexon?

Through the engineering of biology, Intrexon is helping to address some of the world’s most pressing challenges and is working with industry and government leaders to realize a better, healthier planet. Today our platform is delivering new therapies in health, supplying unique solutions to address global energy demand, developing unparalleled features and productivity advancements in food, creating innovative applications for consumers, and helping to restore and protect the environment. Intrexon and our collaborators are building solutions to challenging issues across fields as diverse as medicine, fuel, agriculture, nutrition, personal care, chemicals, and manufacturing, forging a sustainable path forward for current and future generations. We call our approach Better DNA® and invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook and LinkedIn. (NASDAQ: $XON)

keywords:N/A

N/A

Total Funding

100

Number of Employees

$15.5M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Intrexon News

2022-04-19 - Bioinformatics Market is Going to Boom with Dnanexus ...

Dnanexus, Inc. Genedata AG Intrexon Bioinformatics Germany GmbH. Illumina, Inc. PerkinElmer, Inc. QIAGEN N.V.. Seven Bridges Genomics, Inc. Thermo...

2022-04-19 - Biotech Company Allonnia Appoints Lieutenant General (Ret.) Thomas P. Bostick to Board of Directors; Celebrates Additions to Advisory Team

Lieutenant General (Ret.) Thomas P. Bostick previously served as COO and President, Intrexon Bioengineering (NASDAQ: XON). He serves as a senior...

2022-04-19 - Synthetic Biology Market Size, Scope And Outlook | Cyrus ...

Cyrus Biotechnology Inc. (U.S.), Intrexon Corporation (U.S.), GenScript Biotech Corporation (China), Integrated DNA Technologies,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.8M1009%N/A
#2
$7.5M1025%N/A
#3
$34.7M10515%N/A
#4
$23.8M1055%N/A
#5
$99M105-1%$525.8M